Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MEG3
   Synonyms MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1
   Region GRCh38_14:100779410-100861031    Sequence
   Ensembl ENSG00000214548
   RefSeq NR_002766
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name acute myeloid leukemia
   ICD-0-3  M9861/3
   Methods MSP-PCR etc.
   Sample bone marrow
   Expression Pattern down-regulated
   Function Description

MEG3 hypermethylation occurred in 15 MDS patients (34.9%), and in 20 AML patients (47.6%). SNRPN hypermethylation was observed in 15 MDS patients (34.9%), and in 21 AML patients (50%). There were no significant correlations between WHO subtype, WPSS score, karyotype, haemoglobin levels, white blood cell count, platelet count and CpG methylation of any gene. MEG3 hypermethylation was associated with significantly reduced overall survival in individuals with AML, while SNRPN CpG methylation was not associated with survival.

   Pubmed ID 19595458
   Year 2010
   Title CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
   External Links
   Links for  MEG3 GenBank       HGNC       lncrnadb       Noncode
   Links for  acute myeloid leukemia Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.